Early Action Review of Detection, Notification, and Response Timeliness during Cross-Border Bundibugyo Virus Disease Outbreak, Uganda, 2026.

IF 7.9 2区医学 Q1 IMMUNOLOGY

Emerging Infectious Diseases Pub Date : 2026-10-01 DOI:10.3201/eid3210.261411

Joshua Kayiwa, Mudarshiru Bbuye, Ritah Atuhaire, Doreen Nyakato, Mathew Tut, Bayad Nozad, Jovan Baryamujura, Bernard Lubwama, Solome Okware, Pamela Kajumba, Grace Akello, Bonny Kintu, Rebecca Kahunde, Dativa Aliddeki, Motuma Guyassa, Lydia Nakiire, Felix Ocom, Paul Mbaka, Peter Elyanu, Allan Muruta, Atek Kagirita, Charles Olaro

{"title":"Early Action Review of Detection, Notification, and Response Timeliness during Cross-Border Bundibugyo Virus Disease Outbreak, Uganda, 2026.","authors":"Joshua Kayiwa, Mudarshiru Bbuye, Ritah Atuhaire, Doreen Nyakato, Mathew Tut, Bayad Nozad, Jovan Baryamujura, Bernard Lubwama, Solome Okware, Pamela Kajumba, Grace Akello, Bonny Kintu, Rebecca Kahunde, Dativa Aliddeki, Motuma Guyassa, Lydia Nakiire, Felix Ocom, Paul Mbaka, Peter Elyanu, Allan Muruta, Atek Kagirita, Charles Olaro","doi":"10.3201/eid3210.261411","DOIUrl":null,"url":null,"abstract":"<p><p>Bundibugyo virus disease (BVD), an Ebola virus species with no licensed vaccine or therapeutic, reemerged in May 2026 as a cross-border outbreak in Uganda and the Democratic Republic of the Congo. During a 2-day workshop, July 8-9, 2026, we conducted an early action review of the outbreak response using the 7-1-7 framework (7 days to detect, 1 day to notify, 7 days to complete early response actions) to assess timeliness and identify bottlenecks and enablers across 9 response pillars. Uganda declared its outbreak on May 15, 2026; by July 8, the country had recorded 20 confirmed cases (15 imported, 5 locally transmitted) and a case-fatality rate of 15%. Uganda met all 3 targets: detection in 6 days, notification in <1 day, and response completion in 2 days. Low clinical suspicion, cross-border data-sharing gaps, fragmented digital systems, and delayed community engagement were common bottlenecks; strong leadership and coordination structures were most cited enablers.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":"32 10","pages":"1543-1550"},"PeriodicalIF":7.9000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13632832/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3210.261411","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Bundibugyo virus disease (BVD), an Ebola virus species with no licensed vaccine or therapeutic, reemerged in May 2026 as a cross-border outbreak in Uganda and the Democratic Republic of the Congo. During a 2-day workshop, July 8-9, 2026, we conducted an early action review of the outbreak response using the 7-1-7 framework (7 days to detect, 1 day to notify, 7 days to complete early response actions) to assess timeliness and identify bottlenecks and enablers across 9 response pillars. Uganda declared its outbreak on May 15, 2026; by July 8, the country had recorded 20 confirmed cases (15 imported, 5 locally transmitted) and a case-fatality rate of 15%. Uganda met all 3 targets: detection in 6 days, notification in <1 day, and response completion in 2 days. Low clinical suspicion, cross-border data-sharing gaps, fragmented digital systems, and delayed community engagement were common bottlenecks; strong leadership and coordination structures were most cited enablers.

查看原文本刊更多论文

跨界本迪布焦病毒病暴发期间检测、通报和反应及时性的早期行动审查，乌干达，2026年。

本迪布焦病毒病（BVD）是一种没有获得许可的疫苗或治疗方法的埃博拉病毒，于2026年5月在乌干达和刚果民主共和国再次出现跨境疫情。在2026年7月8日至9日为期两天的研讨会期间，我们使用7-1-7框架（7天发现，1天通知，7天完成早期应对行动）对疫情应对进行了早期行动审查，以评估及时性并确定9个应对支柱的瓶颈和推动因素。乌干达于2026年5月15日宣布疫情爆发；截至7月8日，确诊病例20例（输入性15例，本地传播性5例），病死率为15%。乌干达实现了所有3个目标：在6天内发现病例，在6天内通报

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.